goat polyclonal anti anxa1 r d systems cat (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
93
Structured Review
R&D Systems
goat polyclonal anti anxa1 r d systems cat
Goat Polyclonal Anti Anxa1 R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+polyclonal+anti+anxa1+r+d+systems+cat/Human%2FMouse%2FRat+Annexin+A1+Antibody/pm39079535-257-74-77
Average 93 stars, based on 19 article reviews
Goat Polyclonal Anti Anxa1 R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+polyclonal+anti+anxa1+r+d+systems+cat/Human%2FMouse%2FRat+Annexin+A1+Antibody/pm39079535-257-74-77
Average 93 stars, based on 19 article reviews
goat polyclonal anti anxa1 r d systems cat - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Recombinant:Article Title: Cancer stem cells release interleukin-33 within large oncosomes to promote immunosuppressive differentiation of macrophage precursors. Article Snippet: In brief Interleukin (IL)-33 release is associated with cell death in the tumor microenvironment, and it has varied effects on tumor development and progression.. In a model of squamous cell carcinoma, Erickson et al. show that cancer stem cells produce large oncosomes that deliver IL-33 specifically to niche macrophage precursors, promoting the differentiation of these cells into an immune-suppressive phenotype. Synthesized:Article Title: Cancer stem cells release interleukin-33 within large oncosomes to promote immunosuppressive differentiation of macrophage precursors. Article Snippet: In brief Interleukin (IL)-33 release is associated with cell death in the tumor microenvironment, and it has varied effects on tumor development and progression.. In a model of squamous cell carcinoma, Erickson et al. show that cancer stem cells produce large oncosomes that deliver IL-33 specifically to niche macrophage precursors, promoting the differentiation of these cells into an immune-suppressive phenotype. Imaging:Article Title: Cancer stem cells release interleukin-33 within large oncosomes to promote immunosuppressive differentiation of macrophage precursors. Article Snippet: In brief Interleukin (IL)-33 release is associated with cell death in the tumor microenvironment, and it has varied effects on tumor development and progression.. In a model of squamous cell carcinoma, Erickson et al. show that cancer stem cells produce large oncosomes that deliver IL-33 specifically to niche macrophage precursors, promoting the differentiation of these cells into an immune-suppressive phenotype. Selection:Article Title: Cancer stem cells release interleukin-33 within large oncosomes to promote immunosuppressive differentiation of macrophage precursors. Article Snippet: In brief Interleukin (IL)-33 release is associated with cell death in the tumor microenvironment, and it has varied effects on tumor development and progression.. In a model of squamous cell carcinoma, Erickson et al. show that cancer stem cells produce large oncosomes that deliver IL-33 specifically to niche macrophage precursors, promoting the differentiation of these cells into an immune-suppressive phenotype. |